Federal Register / Vol. 79, No. 230 / Monday, December 1, 2014 / Notices 71105 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–28193 Filed 11–28–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Fee Schedule for Reference Biological 

Standards and Biological Preparations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: General notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS) announces that 

HHS/CDC has reviewed and updated its 

fee schedule for reference biological 

standards and biological preparations 

required by OMB Circular A–25, User 

Charges. This notice also announces 

current contact information to obtain 

information on the availability of these 

products and the fees for these products. 

DATES: These fees are effective January 

2, 2015. 

FOR FURTHER INFORMATION CONTACT: To 

obtain information on the current 

inventory of reference biological 

standards and biological preparations 

and the current fee schedule, please 

contact the Division of Scientific 

Resources, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE., 

Mailstop C–17, Atlanta, Georgia 30329; 

telephone 404–639–3466. Someone will 

be available to answer your inquiry 

between 8:00 a.m. and 4:30 p.m. Eastern 

Time, Monday through Friday, except 

on Federal holidays. 

SUPPLEMENTARY INFORMATION: On July 

22, 2013 HHS/CDC published a Direct 

Final Rule (DFR) titled ‘‘Distribution of 

Reference Biological Standards and 

Biological Preparations (78 FR 43817). 

In the DFR, HHS/CDC updated the 

agency name, location, and contact 

information for persons interested in 

obtaining reference biological standards 

and biological preparations. 

On August 5, 2013, HHS/CDC 

published a General Notice (78 FR 

47319) to inform the public that HHS/ 

CDC has reviewed and updated its fee 

schedule per the requirements in OMB 

Circular A–25 (User Charges) and to 

provide contact information to obtain a 

current inventory of products and an 

up-to-date fee schedule of charges (see 

FOR FURTHER INFORMATION CONTACT). 

OMB Circular A–25 (User Charges) 

requires that agencies review user 

charges for agency programs every two 

years. This review should include any 

adjustment to reflect changes in costs or 

market value. HHS/CDC has conducted 

a review of the fees charged for 

reference biological standards and 

biological preparations. Based on this 

review, some reagents are being 

removed from our inventory because 

they are obsolete. No prices have 

increased or decreased at this time. 

HHS/CDC prepares reference 

biological standards and biological 

preparations under the authority of 42 

CFR Part 7. These regulations describe 

how private entities may obtain 

reference biological standards and 

biological preparations from HHS/CDC 

and how charges for these standards and 

preparations are determined. Persons 

interested in these products should 

contact the Division of Scientific 

Resources, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE., 

Mailstop C–17, Atlanta, Georgia 30329; 

telephone 404–639–3466, for the current 

inventory and fee schedule. Due to the 

changing inventory of the unique 

biological standards or biological 

preparations, some of which are 

prepared only upon request, it is best to 

contact HHS/CDC to determine the 

availability of a particular product. 

Dated: November 25, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2014–28226 Filed 11–28–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 79 FR 32739–32740, 

dated June 7, 2014) is amended to 

reflect the reorganization of the National 

Center for Immunization and 

Respiratory Diseases. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the title and the 

mission and function statements for the 

Immunization Services Division (CVGB) 

and insert the following: 

Immunization Services Division 

(CVGB). The Immunization Services 

Division (ISD) protects individuals and 

communities from vaccine-preventable 

diseases through provision of federal 

funds and contracts to purchase and 

distribute vaccine, provision of 

technical and financial support of 

immunization programs, provider and 

public education, and evaluation and 

research. 

Office of the Director (CVGB1). (1) 

Coordinates the division’s program, 

policy, scientific activities and provides 

leadership for domestic programmatic 

activities; (2) links strategies and 

priorities of the primarily programfocused ISD branches with other NCIRD 

divisions working in the area of 

domestic immunizations and vaccinepreventable diseases; (3) facilitates 

development and ongoing 

implementation of vaccine coverage 

surveillance, health services and 

economic research, and program 

evaluation across the ISD branches; (4) 

interfaces with other CDC CIOs working 

in the area of immunizations and 

vaccine preventable diseases; (5) 

provides guidance for the protection of 

research subjects, OMB/PRA 

compliance, and scientific review and 

clearance of manuscripts and other 

written materials produced by ISD 

branches; (6) provides leadership for 

domestic adult immunizations in the 

ISD; (7) provides leadership across the 

branches with respect to linking 

preparedness and response elements to 

the overall influenza prevention and 

control strategy, and interfaces with 

other parts of CDC with this strategy; (8) 

represents ISD in other preparedness 

activities with vaccines as 

countermeasures; (9) in close 

coordination with NCIRD’s Office of 

Policy, provides policy support to the 

ISD; (10) as appropriate, works through 

the NCIRD Office of Policy to serve as 

liaison to other policy offices, other 

government agencies, and external 

partners on policy, program, legislative, 

and budgetary issues related to ISD; (11) 

conducts policy analysis; (12) advises 

ISD leadership on policy and 

partnership issues and supports Center 

efforts in the management of 

Congressional and government 

relations; (13) manages cross-cutting 

policy issues within ISD and, as 

appropriate, with other policy offices 

within the Center and CDC; (14) 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
71106 Federal Register / Vol. 79, No. 230 / Monday, December 1, 2014 / Notices 

provides direct management oversight 

and execution of national vaccine 

supply contracts; (15) provides direct 

management and execution of 

procurement requisitions, contracts, and 

cooperative agreements, and performs 

administrative tasks related to initiating, 

processing, and maintaining interagency 

agreements; (16) provides direct 

management and execution of the 

administrative aspects of human 

resources across ISD, including training, 

and administration of policies and 

guidelines developed among others, by 

the Department of Health & Human 

Services, CDC Ethics Office, Office of 

the Chief Financial Officer, Office of 

Commissioned Corps Personnel, Office 

of Personnel Management, and 

Procurement and Grants Office; (17) 

provides direct management and 

execution of the coordination of office 

facilities, and supplies technical 

guidance and expertise regarding 

occupancy and facilities management 

including emergency situations; (18) 

provides direct and daily management 

and execution of the distribution, 

accountability, and maintenance of CDC 

property and equipment; and (19) 

provides direct and daily management 

and execution of domestic travel 

processing for federal employees, 

Commissioned Corps, and all CDCinvited guests. 

Program Operations Branch (CVGBB). 

(1) Serves as CDC’s primary interface 

with eligible immunization cooperative 

agreement awardees, supporting the 

awardees with development, 

implementation, assessment, and 

promotion of immunization-related 

activities with the goal of achieving and 

sustaining high immunization coverage 

level; (2) administers the Vaccines For 

Children (VFC) and Section 317 

programs for eligible awardees; (3) 

provides technical assistance to 

awardees on program implementation, 

including implementation of all 

components of the VFC and Section 317 

cooperative agreement; (4) monitors 

VFC and Section 317 cooperative 

agreement awardee performance; (5) 

manages immunization field staff; (6) 

supports efforts to assure accountability 

in the use of vaccines purchased with 

federal funding; (7) assures 

accountability of federal funds used to 

purchase vaccines; and (8) identifies 

and evaluates methods to improve 

immunization service delivery. 

Vaccine Supply and Assurance 

Branch (CVGBC). (1) Oversees all 

aspects of domestic vaccine purchase 

and distribution; (2) manages 

centralized vaccine distribution 

contracts; (3) establishes and manages 

vaccine purchase contracts; (4) creates 

and maintains pediatric vaccine 

stockpiles; (5) coordinates and reviews 

awardee spend plans for vaccine 

ordering; (6) manages national vaccine 

supply shortages, including public 

vaccine allocations when needed; (7) 

tracks and monitors national seasonal 

influenza vaccine distribution; (8) 

conducts data analyses related to 

vaccine purchase and distribution; (9) 

provides storage and handling technical 

assistance; (10) provides awardee 

support and conducts planning and 

testing in Vaccine Tracking System 

(VTrckS); and (11) develops VFC 

program resolutions for the Advisory 

Committee on Immunization Practices 

(ACIP). 

Immunization Information Systems 

Support Branch (CVGBE). (1) Supports 

the CDC vision of ‘‘A nation without 

vaccine-preventable disease, disability, 

and death’’ by making high quality data 

from immunization information systems 

(ITS) available to clinical, 

administrative, public health, and other 

immunization stakeholders; (2) provides 

leadership, operational, technical and 

resource support to develop a 

nationwide network of fully operational 

and integrated IIS and other health 

systems; (3) ensures high-quality IIS 

data and system functionality by 

identifying, developing, implementing, 

promoting, and evaluating standards 

and best practices; (4) promotes the 

effective use of IIS data and system 

functions to support vaccination 

providers, public health programs, other 

immunization stakeholders, and policy 

needs; (5) monitors, evaluates, and 

reports emerging industry and 

environmental trends that influence IIS 

operations; and (6) supports the 

exchange of information about IIS and 

collaborative efforts to advance ITS 

operations with partners. 

Assessment Branch (CVGBG). (1) Lead 

domestic vaccination coverage 

assessment across the lifespan; (2) 

assess the impact of interventions, 

policies and disseminating and 

promoting use of this information to 

improve vaccination coverage; (3) 

conducts assessment of vaccination 

coverage, related health services, and 

other factors associated with 

vaccination across the lifespan; (4) 

conducts and manages the National 

Immunization Survey (NIS) to assess 

vaccination coverage and related 

information among children aged 19–35 

months and 13–17 years, and as needed, 

other age groups; (5) collects, analyzes, 

and disseminates accurate and timely 

vaccination coverage and related 

information using the NIS and other 

survey mechanisms and clinical data 

sources; (6) assists national, state and 

local immunization programs in 

collection, analysis, interpretation, and 

use of vaccination coverage assessment 

and evaluation information to guide 

policy and program activities; (7) 

conducts research and evaluations to 

assess and reduce racial/ethnic and 

other disparities in vaccination, 

evaluate impact of interventions, 

policies, and program activities on 

vaccination coverage, and measure 

disease and economic impact of specific 

interventions and vaccination programs; 

and (8) conducts research to evaluate 

and improve the validity and costeffectiveness of NIS and other 

assessment systems used to collect 

vaccination coverage data. 

Communication and Education 

Branch (CVGBH). (1) Works through 

communications and educational efforts 

to improve knowledge and influence 

changes in behavior of domestic health 

care providers and the general public to 

reduce vaccine-preventable diseases 

across the life span; (2) collaborate with 

NCIRD Health Communication Science 

Office (HCSO) to develop 

communications strategies and provide 

communications and media support for 

ISD; (3) develops and disseminates 

domestic immunization messages, 

materials, and educational offerings for 

health care providers and consumers 

related to ISD’s scientific and 

programmatic work; (4) supports the 

CDC immunization response system; (5) 

collaborates with national 

immunization partner groups to achieve 

programmatic goals; (6) through NCIRD 

HCSO provides technical assistance for 

national immunization communications 

campaigns; (7) provides Continuing 

Education credits for immunizationrelated education and training products; 

and (8) participates on the ACIP work 

groups and develops and promotes 

ACIP schedules and recommendations. 

Dated: October 29, 2014. 

Sherri A. Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2014–28220 Filed 11–28–14; 8:45 am] 

BILLING CODE 4160–18–M 


asabaliauskas on DSK5VPTVN1PROD with NOTICES